BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9565204)

  • 1. Profiles of heroin addicts in different treatment conditions and in the community.
    Eland-Goossensen MA; van de Goor IA; Benschop AJ; Garretsen HF
    J Psychoactive Drugs; 1998; 30(1):11-20. PubMed ID: 9565204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
    Blanken P; Hendriks VM; van Ree JM; van den Brink W
    Addiction; 2010 Feb; 105(2):300-8. PubMed ID: 19922517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating heroin addiction: comparison of methadone therapy, hospital therapy without methadone, and therapeutic community.
    Vidjak N
    Croat Med J; 2003 Feb; 44(1):59-64. PubMed ID: 12590430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin addicts in the community and in treatment compared for severity of problems and need for help.
    Eland-Goossensen A; van de Goor IA; Garretsen HF
    Subst Use Misuse; 1997 Aug; 32(10):1313-30. PubMed ID: 9286002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of methadone therapy at the Institute for Alcoholism and Drug Addiction in the Canton of Sarajevo].
    Hasecić H; Mehić-Basara N; Pokrajac M; Marjanović-Cengić S; Selman S; Ploskić S; Ramić L; Balić A; Grabovica M; Havić E; Sukurović N
    Med Arh; 2003; 57(5-6 Suppl 1):29-32. PubMed ID: 15022566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structured environment for heroin addicts: the experiences of a community-based American methadone clinic and a residential Dutch therapeutic community.
    Bratter TE; Kooyman M
    Int J Soc Psychiatry; 1981; 27(3):189-203. PubMed ID: 7327867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China.
    Chen W; Li X; Li X; Ling L; Xia Y; Chen J; He Q
    J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential substance abuse patterns distribute according to gender in heroin addicts.
    Maremmani I; Stefania C; Pacini M; Maremmani AG; Carlini M; Golia F; Deltito J; Dell'Osso L
    J Psychoactive Drugs; 2010 Mar; 42(1):89-95. PubMed ID: 20464810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort.
    Vigna-Taglianti FD; Burroni P; Mathis F; Versino E; Beccaria F; Rotelli M; Garneri M; Picciolini A; Bargagli AM;
    Subst Use Misuse; 2016; 51(3):295-309. PubMed ID: 26872763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
    Maremmani I; Pani PP; Mellini A; Pacini M; Marini G; Lovrecic M; Perugi G; Shinderman M
    J Addict Dis; 2007; 26(1):61-70. PubMed ID: 17439869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F; Manzato E; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Key Extended Entry Program (KEEP): from the community side of the bridge.
    Fallon BM
    Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A psychosocial typology of drug addicts and implications for treatment.
    Cohen A
    Int J Addict; 1986 Feb; 21(2):147-54. PubMed ID: 3710644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heroin addicts in substitution programs].
    Baumann T; Battegay R; Rauchfleisch U
    Schweiz Med Wochenschr; 1993 May; 123(20):1020-6. PubMed ID: 8511533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Rorschach's test for heroin addicts treated by methadone: from reality to imaginary].
    Deslandes C; Gourarier L; Sanchez M; Lowenstein W
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B61-4. PubMed ID: 11104948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.